120 related articles for article (PubMed ID: 6575209)
1. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS
J Natl Cancer Inst; 1983 Jul; 71(1):5-9. PubMed ID: 6575209
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for fibrocystic breast disease and its histopathologic components.
Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use and fibrocystic breast disease of different histologic classifications.
Hsieh CC; Crosson AW; Walker AM; Trapido EJ; MacMahon B
J Natl Cancer Inst; 1984 Feb; 72(2):285-90. PubMed ID: 6582316
[TBL] [Abstract][Full Text] [Related]
4. Exogenous hormone use and fibrocystic breast disease by histopathologic component.
Berkowitz GS; Kelsey JL; LiVolsi VA; Merino MJ; Holford TR; Hildreth NG; Ort S; O'Connor TZ; White C
Int J Cancer; 1984 Oct; 34(4):443-9. PubMed ID: 6490201
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women.
Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; Goldenberg IS; White C
Am J Epidemiol; 1984 Jul; 120(1):87-96. PubMed ID: 6741927
[TBL] [Abstract][Full Text] [Related]
6. An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia.
Pastides H; Kelsey JL; Holford TR; LiVolsi VA
Am J Epidemiol; 1985 Mar; 121(3):440-7. PubMed ID: 4014134
[TBL] [Abstract][Full Text] [Related]
7. Oral contraception and breast pathology.
Ragni N; Boccardo E; Viglino S; Larosa E
Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and reduced risk of benign breast diseases.
Ory H; Cole P; MacMahon B; Hoover R
N Engl J Med; 1976 Feb; 294(8):419-22. PubMed ID: 1246309
[TBL] [Abstract][Full Text] [Related]
9. Cystic disease, family history of breast cancer, and use of oral contraceptives.
Vakil DV; Elinson L; Morgan RW
Cancer Detect Prev; 1981; 4(1-4):511-5. PubMed ID: 7349817
[TBL] [Abstract][Full Text] [Related]
10. Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia.
LiVolsi VA; Stadel BV; Kelsey JL; Holford TR; White C
N Engl J Med; 1978 Aug; 299(8):381-5. PubMed ID: 566853
[TBL] [Abstract][Full Text] [Related]
11. A cohort study of oral contraceptive use and risk of benign breast disease.
Rohan TE; Miller AB
Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and histopathology of cancerous breasts in young women. Members of the U.K. National Case-Control Study Group.
Hulman G; Trowbridge P; Taylor CN; Chilvers CE; Sloane JP
J Pathol; 1992 Aug; 167(4):407-11. PubMed ID: 1403359
[TBL] [Abstract][Full Text] [Related]
13. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
14. [Breast diseases (fibroadenomas, mastopathies, breast cancers) in hormonal contraception].
Nizze H; Kändler U
Zentralbl Gynakol; 1988; 110(20):1296-302. PubMed ID: 3239299
[TBL] [Abstract][Full Text] [Related]
15. Exogenous estrogens and other factors in the epidemiology of breast cancer.
Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C
J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372
[TBL] [Abstract][Full Text] [Related]
16. Estrogen replacement therapy and fibrocystic breast disease.
Pastides H; Najjar MA; Kelsey JL
Am J Prev Med; 1987; 3(5):282-6. PubMed ID: 2838061
[TBL] [Abstract][Full Text] [Related]
17. Benign breast disease and consumption of beverages containing methylxanthines.
La Vecchia C; Franceschi S; Parazzini F; Regallo M; Decarli A; Gallus G; Di Pietro S; Tognoni G
J Natl Cancer Inst; 1985 May; 74(5):995-1000. PubMed ID: 3858587
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
19. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
20. Age at first birth and breast atypia.
Hsieh CC; Walker AM; Trapido EJ; Crosson AW; MacMahon B
Int J Cancer; 1984 Mar; 33(3):309-12. PubMed ID: 6698636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
